NYSEMKT: ATNM
Actinium Pharmaceuticals Inc Earnings Dates, Reports, Calls

Actinium Pharmaceuticals earnings were -$40.9M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest ATNM earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$11.6M, up 1.9% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ATNM reported annual earnings of -$48.8M, with 47.9% growth. The next ATNM earnings date is Apr 24, 2025.

ATNM earnings history

Current Revenue
$81.0k
Current Earnings
-$40.9M
Current Profit Margin
-50,512.3%

ATNM Return on Equity

Current Company
-100.9%
Current Industry
19.9%
Current Market
35%
ATNM's Return on Equity (-100.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ATNM undefined

Current Company
-47.9%
Current Industry
1.3%
ATNM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ATNM announces earnings.

ATNM undefined

Current Company
-55.02%
Current Industry
14.3%
ATNM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATNM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ATNM-$40.11M-$40.92MN/A-$1.39
ALGS-$132.66M-$131.21MN/A-$20.94
IMRX-$60.32M-$61.04MN/A-$2.04
ARMP-$6.85M-$18.92MN/A-$0.52
PMVP-$73.91M-$58.71MN/A-$1.14

ATNM earnings dates

Next earnings date
Apr 24, 2025

Actinium Pharmaceuticals Earnings Reports & History FAQ

What were Actinium Pharmaceuticals's earnings last quarter?

On ATNM's earnings call on Invalid Date, Actinium Pharmaceuticals (NYSEMKT: ATNM) reported Q3 2024 earnings per share (EPS) of -$0.37, up 24.49% year over year. Total ATNM earnings for the quarter were -$11.57 million. In the same quarter last year, Actinium Pharmaceuticals's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Actinium Pharmaceuticals stock.

When does Actinium Pharmaceuticals report earnings?

The next ATNM earnings date is Invalid Date. Add ATNM to your watchlist to be reminded of Actinium Pharmaceuticals's next earnings date.

What was ATNM's earnings growth in the past year?

As of Actinium Pharmaceuticals's earnings date in Invalid Date, Actinium Pharmaceuticals's earnings has grown year over year. ATNM earnings in the past year totalled -$40.92 million.

Is Actinium Pharmaceuticals profitable or losing money?

As of the last Actinium Pharmaceuticals earnings report, Actinium Pharmaceuticals is currently losing money. Actinium Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$40.92 million, a 18.4% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.